Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...
Bayer AG BAYRY reported fourth-quarter 2025 core earnings of 18 cents per American Depositary Receipt (ADR), in line with the ...
Dr Fred Saad of the University of Montreal discusses the future direction of alpha emitter agents in the treatment of prostate cancer, emphasizing the logical progression of resea ...
Docetaxel added to androgen deprivation therapy (ADT) was the most cost-effective first-line regimen for patients with ...
Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...
By Puyaan Singh and Sahil Pandey March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ...
For Patients With mCRPC, Results With Pluvicto in Real-World Settings Keep Pace With Clinical Trials
Real-world PRECISION data in 500 taxane-naïve, PSMA-positive mCRPC patients showed median PFS 13.5 months (95% CI, 11.7–14.7), aligning with PSMAfore efficacy expectations. Earlier sequencing mattered ...
A breakthrough AI system is revolutionizing cancer immunotherapy by enabling scientists to design protein-based keys that train a patient s immune cells to attack cancer with extreme precision. This ...
SPOTTING the first signs of baldness in the mirror can be a moment of true horror for many men. But could the dreaded bald patch finally be beaten – with lab-grown hair? That’s the potential ...
News-Medical.Net on MSN
Six federal scientists run out by Trump talk about the work left undone
Marc Ernstoff, a physician who has pioneered immunotherapy research and treatments for cancer patients, said his work as a federal scientist proved untenable under the Trump administration. Philip ...
The Hearty Soul on MSN
Doctors are finally admitting that biopsies spread cancer
The word "cancer" alone is enough to send a chill down anyone's spine. When a doctor follows that word with the recommendation for a biopsy, the anxiety often doubles. Though many of us aren't even ...
Welcome to our conference call to review Q4 and full year 2025 and to look into 2026. To begin, Bill will share his perspective on our business development, the progress we've made in our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results